title: Clinical Utility of Bone Marrow Study in Gaucher Disease: A Case Report of Gaucher Disease Type 3 With Intractable Myoclonic Seizures.
authors.affiliation: Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: John Hoon
authors.initials: JH
authors.lastname: Rim
authors.affiliation: Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Minyoul
authors.initials: M
authors.lastname: Baik
authors.affiliation: Department of Pathology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Sun Och
authors.initials: SO
authors.lastname: Yoon
authors.affiliation: Department of Neurology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
authors.forename: Kyoung
authors.initials: K
authors.lastname: Heo
authors.affiliation: Department of Laboratory Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. labdx@yuhs.ac.
authors.forename: Jaewoo
authors.initials: J
authors.lastname: Song
mesh_terms: D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology*; D004831:Epilepsies, Myoclonic / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D005260:Female; D005776:Gaucher Disease / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D005962:Glucosylceramidase / Q000235:genetics / Q000627:therapeutic use; D006801:Humans; D010641:Phenotype; D017354:Point Mutation; D012008:Recurrence
chemical_list: D000927:Anticonvulsants; D005962:Glucosylceramidase; C090568:imiglucerase